Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Buy NowAutoimmune Diseases Diagnostics Market Outlook
Global Autoimmune Diseases Diagnostics Market is projected to be valued at around US$ 8.64 Billion by 2030, according to Renub Research. Autoimmune diseases are diverse situations wherein the immune system mistakenly attacks the body's cells, tissues, and organs. These outcomes result in irritation and harm, causing various symptoms. Over 80 diagnosed autoimmune diseases, together with rheumatoid arthritis, lupus, and type 1 diabetes, affect millions globally. The precise motive is frequently unknown, related to a complex exchange of genetic and environmental elements. Symptoms range widely, impacting more than one system and organ. Diagnosing autoimmune sicknesses may be challenging, regularly requiring specialized testing. Treatment aims to cope with signs and symptoms and modulate the immune response, improving the patient's friendly life.
According to NCBI, approximately 5% of the world’s population suffers from autoimmune disorders, which are lifelong and functionally diverse and are steadily increasing in Westernized societies. Immune reactions that are targeted toward self-antigens can eventually lead to the destruction of the host’s cells and the improvement of autoimmune diseases. Although autoimmune disorders are comparatively rare, the global incidence and prevalence are growing, and they have substantial damaging implications for mortality and morbidity.
Global Autoimmune Diseases Diagnostics Market is projected to experience a CAGR of 7.17% between 2024 and 2030
The growing old global population, specifically susceptible to autoimmune illnesses, fuels a growing diagnostics market. This demographic shift opens a new and expanding phase for diagnostics, contributing to a heightened market boom. The market studies a banquet of new biomarkers and tests for rarer autoimmune diseases, catering to numerous patients' needs. The market is increasing with rising healthcare spending, propelled by improved public and private funding globally. Expanded insurance coverage, in addition, complements accessibility to diagnostics, making these tests available to a broader population. This combination creates a flourishing market environment with various services and financial support.
Surging cognizance prompts early consultations for autoimmune illnesses, propelling the demand for specialized diagnostics and personalized treatment plans. Leveraging autoantibody assays, genetic testing, imaging, and diagnostics offers particular results. Robots streamline labs, while point-of-care testing complements accessibility. AI accurately predicts sickness dangers, promising a vibrant future for customized treatments. In the United States, the autoimmune disease diagnostics market is projected to develop appreciably because of new product introductions and the presence of primary companies. These elements contribute to the market's dominance and expected increase throughout the forecast period. Hence, the worth of the Global Autoimmune Diseases Diagnostics Market was US$ 5.32 Billion in 2023.
Diagnostics Equipment has a solid claim to the leading position in the global autoimmune diseases diagnostics market
By product, the global autoimmune diseases diagnostics market is fragmented into Therapeutic & Monitoring Equipment, Diagnostics Equipment, and Drugs. An accurate and well-timed prognosis is vital in dealing with autoimmune diseases. Diagnostics Equipment, from blood analyzers to imaging systems, identifies situations early, improving effects. With a vast variety of tests, such as specialized imaging, it caters to various needs. Technological advancements, like AI and automation, drive growth. Rising occurrence fuels demand for supporting innovation. Personalized treatment is based on correct analysis. Supportive regulations and insurance coverage enhance accessibility. Streamlined workflows and automation lessen mistakes. Early intervention ability promises disease prevention.
Systemic autoimmune diseases (SADs) hold a significant portion of the global autoimmune diseases diagnostics market
The global autoimmune diseases diagnostics market is segmented into Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics. Systemic autoimmune diseases (SADs) impose considerable morbidity and mortality, often necessitating lifelong treatment and monitoring, hence driving demand for specialized diagnostics. Notable improvements, including noticeably precise autoantibody assays, genetic testing for susceptibility markers, and advanced imaging strategies, enhance diagnostics accuracy and efficiency, bolstering market growth. Early detection is pivotal in coping with SADs efficaciously, lowering disease development and organ damage, thereby fostering demand for reachable and precise diagnostics tools. With elevated consciousness of SADs and their effects, individuals are proactively in search of medical interest and screening tests, in addition to stimulating market enlargement.
Rheumatic disease diagnostics occupy a substantial share in the autoimmune diseases diagnostics market
By indication, the global autoimmune diseases diagnostics market is categorized into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Others. Rheumatic diseases, affecting 1 in 4 adults globally, fuel tremendous demand for diagnostics. Diverse subtypes like rheumatoid arthritis and lupus require precise diagnostics techniques, propelling the improvement of a vast range of tests. Diagnosis complexity, with overlapping signs, mandates advanced strategies like autoantibody assays and genetic testing. Early detection is essential for capable management and decreasing joint damage. Research emphasizes novel diagnostics Equipment, enhancing accuracy and permitting personalized medicine. This shift towards tailor-made remedies underscores the significance of correct diagnostics in predicting disorder development and guiding interventions.
Diagnostics centers are expected to hold a significant share in the global autoimmune diseases diagnostics market
By end-users, the global autoimmune diseases diagnostics market is divided into Hospitals, Diagnostics Centers, and Others. Specialized diagnostics centers excel in autoimmune disease, testing with targeted expertise, and providing quicker, correct diagnoses using cutting-edge technology. They prioritize patient satisfaction because they are cost-effective, easily located, and aligned with value-based care. Collaboration with primary care physicians streamlines referrals, ensuring suitable testing is done. Integrated digital structures enhance efficiency. Amidst the surge in outpatient services, diagnostics facilities become pivotal in autoimmune disease diagnosis and control, playing a valuable function in the evolving healthcare panorama.
Asia-Pacific is undoubtedly a key player in the global autoimmune diseases diagnostics market, and its potential for continued expansion is significant
By regions, the global autoimmune diseases diagnostics market is broken up into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, and UAE). Asia-Pacific, home to over half the worldwide population, faces a rising burden of autoimmune diseases. According to the Arthritis Foundation of Asia, about 47 percent of diabetes and 49 percent of heart patients are diagnosed with arthritis. The region's adoption of cost-effective diagnostics solutions and growing disposable earnings expand access to diagnostics, propelling market increase. Strategic initiatives, like Avesthagen Limited's alliance with Wipro Limited in June 2022 to commercialize genetic testing in India, similarly make contributions. Partnerships like these are expected to strengthen market expansion in the place.
Key Players
The global autoimmune diseases diagnostics market is comprised of companies such as Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, Bio Merieux SA, Myriad Genetics, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc.
- In August 2022- KSL Beutner Laboratories (Beutner) developed a blood test to detect an antigen associated with mucous membrane pemphigoid (MMP). This autoimmune blistering disease often causes painful lesions in the oral cavity.
- In May 2022- The Phadia 2500+ instruments by ThermoFisher will soon offer reliable and unparalleled high throughput for allergy diagnostics and autoimmune testing in the US.
Renub Research report titled “Global Autoimmune Diseases Diagnostics Market By Product (Therapeutic & Monitoring Equipment, Diagnostics Equipment, and Drugs), Types (Systemic Autoimmune Disease Diagnostics, and Localized Autoimmune Disease Diagnostics), Indication (Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Others), End-Users (Hospitals, Diagnostics Centers, and Others), Countries (North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), Latin America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, and UAE)), Company Analysis (Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, Bio Merieux SA, Myriad Genetics, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc.)” provides a complete study of Global Autoimmune Diseases Diagnostics Industry.
Product – Global Autoimmune Diseases Diagnostics Market breakup in 3 viewpoints:
1. Therapeutic & Monitoring Equipment
2. Diagnostics Equipment
3. Drugs
Types – Global Autoimmune Diseases Diagnostics Market breakup in 2 viewpoints:
1. Systemic Autoimmune Disease Diagnostics
2. Localized Autoimmune Disease Diagnostics
Indication – Global Autoimmune Diseases Diagnostics Market breakup in 5 viewpoints:
1. Rheumatic Disease
2. Diabetes
3. Multiple Sclerosis
4. Inflammatory Bowel Disease
5. Others
End-Users – Global Autoimmune Diseases Diagnostics Market breakup in 3 viewpoints:
1. Hospitals
2. Diagnostics Centers
3. Others
Countries – Global Autoimmune Diseases Diagnostics Market of 25 Countries
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Developments
• Revenue Analysis
Company Analysis:
1. Abbott Laboratories
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Siemens Healthineers
5. Bio Merieux SA
6. Myriad Genetics, Inc.
7. Quest Diagnostics Incorporated
8. Thermo Fisher Scientific Inc.
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2018 – 2023 |
| Forecast Period | 2024 – 2030 |
| Market | US$ Billion |
| Segment Covered | Product, Type, Indication, End User, and Countries |
| Countries Covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa |
| Companies Covered | Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, Bio Merieux SA, Myriad Genetics, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc. |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Autoimmune Disease Diagnostics Market
6. Market Share – Autoimmune Disease Diagnostics Market
6.1 By Product
6.2 By Type
6.3 By Indication
6.4 By End Users
6.5 By Country
7. Product – Autoimmune Disease Diagnostics Market
7.1 Therapeutic & Monitoring Equipment
7.2 Diagnostics Equipment
7.3 Drugs
8. Type – Autoimmune Disease Diagnostics Market
8.1 Systemic Autoimmune Disease Diagnostics
8.2 Localized Autoimmune Disease Diagnostics
9. Indication – Autoimmune Disease Diagnostics Market
9.1 Rheumatic Disease
9.2 Diabetes
9.3 Multiple Sclerosis
9.4 Inflammatory Bowel Disease
9.5 Others
10. End Users – Autoimmune Disease Diagnostics Market
10.1 Hospitals
10.2 Diagnostics Centers
10.3 Others
11. Country – Autoimmune Disease Diagnostics Market
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa
12. Porter’s Five Analysis – Autoimmune Disease Diagnostics Market
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis – Autoimmune Disease Diagnostics Market
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat
14. Companies Analysis
14.1 Abbott Laboratories
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Financial Insights
14.2 Bio-Rad Laboratories
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Financial Insights
14.3 Roche Diagnostics
14.3.1 Overview
14.3.2 Recent Development
14.3.3 Financial Insights
14.4 Siemens Healthineers
14.4.1 Overview
14.4.2 Recent Development
14.4.3 Financial Insights
14.5 BioMerieux SA
14.5.1 Overview
14.5.2 Recent Development
14.5.3 Financial Insights
14.6 Myriad Genetics, Inc.
14.6.1 Overview
14.6.2 Recent Development
14.6.3 Financial Insights
14.7 Quest Diagnostics Incorporated
14.7.1 Overview
14.7.2 Recent Development
14.7.3 Financial Insights
14.8 Thermo Fisher Scientific Inc.
14.8.1 Overview
14.8.2 Recent Development
14.8.3 Financial Insights
List of Figures:
Figure-01: Global – Autoimmune Disease Diagnostics Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Autoimmune Disease Diagnostics Market (Billion US$), 2024 – 2030
Figure-03: Product – Therapeutic & Monitoring Equipment Market (Million US$), 2018 – 2023
Figure-04: Product – Forecast for Therapeutic & Monitoring Equipment Market (Million US$), 2024 – 2030
Figure-05: Product – Diagnostics Equipment Market (Million US$), 2018 – 2023
Figure-06: Product – Forecast for Diagnostics Equipment Market (Million US$), 2024 – 2030
Figure-07: Product – Drugs Market (Million US$), 2018 – 2023
Figure-08: Product – Forecast for Drugs Market (Million US$), 2024 – 2030
Figure-09: Type – Systemic Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-10: Type – Forecast for Systemic Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-11: Type – Localized Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-12: Type – Forecast for Localized Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-13: Indication – Rheumatic Disease Market (Million US$), 2018 – 2023
Figure-14: Indication – Forecast for Rheumatic Disease Market (Million US$), 2024 – 2030
Figure-15: Indication – Diabetes Market (Million US$), 2018 – 2023
Figure-16: Indication – Forecast for Diabetes Market (Million US$), 2024 – 2030
Figure-17: Indication – Multiple Sclerosis Market (Million US$), 2018 – 2023
Figure-18: Indication – Forecast for Multiple Sclerosis Market (Million US$), 2024 – 2030
Figure-19: Indication – Inflammatory Bowel Disease Market (Million US$), 2018 – 2023
Figure-20: Indication – Forecast for Inflammatory Bowel Disease Market (Million US$), 2024 – 2030
Figure-21: Indication – Others Market (Million US$), 2018 – 2023
Figure-22: Indication – Forecast for Others Market (Million US$), 2024 – 2030
Figure-23: End User – Hospitals Market (Million US$), 2018 – 2023
Figure-24: End User – Forecast for Hospitals Market (Million US$), 2024 – 2030
Figure-25: End User – Diagnostics Centers Market (Million US$), 2018 – 2023
Figure-26: End User – Forecast for Diagnostics Centers Market (Million US$), 2024 – 2030
Figure-27: End User – Others Market (Million US$), 2018 – 2023
Figure-28: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-29: United States – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-30: United States – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-31: Canada – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-32: Canada – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-33: France – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-34: France – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-35: Germany – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-36: Germany – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-37: Italy – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-38: Italy – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-39: Spain – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-40: Spain – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-41: United Kingdom – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-42: United Kingdom – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-43: Belgium – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-44: Belgium – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-45: Netherlands – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-46: Netherlands – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-47: Turkey – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-48: Turkey – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-49: China – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-50: China – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-51: Japan – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-52: Japan – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-53: India – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-54: India – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-55: South Korea – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-56: South Korea – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-57: Thailand – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-58: Thailand – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-59: Malaysia – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-60: Malaysia – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-61: Indonesia – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-62: Indonesia – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-63: Australia – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-64: Australia – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-65: Brazil – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-66: Brazil – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-67: Mexico – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-68: Mexico – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-69: Argentina – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-70: Argentina – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-71: Saudi Arabia – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-72: Saudi Arabia – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-73: UAE – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-74: UAE – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-75: South Africa – Autoimmune Disease Diagnostics Market (Million US$), 2018 – 2023
Figure-76: South Africa – Forecast for Autoimmune Disease Diagnostics Market (Million US$), 2024 – 2030
Figure-77: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2023
Figure-78: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-79: Bio-Rad Laboratories – Global Revenue (Billion US$), 2018 – 2023
Figure-80: Bio-Rad Laboratories – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-81: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2023
Figure-82: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-83: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2023
Figure-84: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-85: BioMerieux SA – Global Revenue (Billion US$), 2018 – 2023
Figure-86: BioMerieux SA – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-87: Myriad Genetics, Inc. – Global Revenue (Billion US$), 2018 – 2023
Figure-88: Myriad Genetics, Inc. – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-89: Quest Diagnostics Incorporated – Global Revenue (Billion US$), 2018 – 2023
Figure-90: Quest Diagnostics Incorporated – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-91: Thermo Fisher Scientific Inc. – Global Revenue (Billion US$), 2018 – 2023
Figure-92: Thermo Fisher Scientific Inc. – Forecast for Global Revenue (Billion US$), 2024 – 2030
List of Tables:
Table-01: Global – Autoimmune Disease Diagnostics Market Share by Product (Percent), 2018 – 2023
Table-02: Global – Forecast for Global Autoimmune Disease Diagnostics Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Autoimmune Disease Diagnostics Market Share by Type (Percent), 2018 – 2023
Table-04: Global – Forecast for Global Autoimmune Disease Diagnostics Market Share by Type (Percent), 2024 – 2030
Table-05: Global – Autoimmune Disease Diagnostics Market Share by Indication (Percent), 2018 – 2023
Table-06: Global – Forecast for Global Autoimmune Disease Diagnostics Market Share by Indication (Percent), 2024 – 2030
Table-07: Global – Autoimmune Disease Diagnostics Market Share by End User (Percent), 2018 – 2023
Table-08: Global – Forecast for Global Autoimmune Disease Diagnostics Market Share by End User (Percent), 2024 – 2030
Table-09: Global – Autoimmune Disease Diagnostics Market Share by Countries (Percent), 2018 – 2023
Table-10: Global – Forecast for Global Autoimmune Disease Diagnostics Market Share by Countries (Percent), 2024 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com